Current status of white coat hypertension: where are we?

Nuredini, Gani, Saunders, Alec, Rajkumar, Chakravarthi and Okorie, Michael (2020) Current status of white coat hypertension: where are we? Therapeutic Advances in Cardiovascular Disease, 14. pp. 1-10. ISSN 1753-9447

[img] PDF - Published Version
Available under License Creative Commons Attribution-Non-Commercial.

Download (214kB)

Abstract

White coat hypertension (WCH) is characterised by an elevated clinic blood pressure (BP) with normal ambulatory or home BP. It is well recognised in clinical practice and occurs in approximately one-third of untreated patients with elevated clinic BP. Current evidence suggests that WCH is associated with cardiovascular risk factors, including the development of sustained hypertension and the presence of target organ damage. However, its effects on cardiovascular outcomes remain a matter of debate. There is also insufficient evidence from randomised controlled trials to determine whether WCH warrants treatment. This narrative review aims to provide an update on the current understanding of WCH. It focuses on the clinical characteristics and potential implications of WCH, its relationship to cardiovascular risk and the evidence regarding treatment. Gaps in existing research are also highlighted.

Item Type: Article
Keywords: cardiovascular risk, target organ damage, white coat hypertension
Schools and Departments: Brighton and Sussex Medical School > Brighton and Sussex Medical School
Subjects: R Medicine
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RM Therapeutics. Pharmacology > RM0138 Drug prescribing
Depositing User: Michael Okorie
Date Deposited: 18 Dec 2020 14:48
Last Modified: 18 Dec 2020 15:00
URI: http://sro.sussex.ac.uk/id/eprint/95912

View download statistics for this item

📧 Request an update